4//SEC Filing
Quirk Gerald E 4
Accession 0000950170-24-040297
CIK 0001556263other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 4:57 PM ET
Size
8.6 KB
Accession
0000950170-24-040297
Insider Transaction Report
Form 4
Quirk Gerald E
Chief Legal Officer
Transactions
- Exercise/Conversion
Common Stock
2024-03-27+22,500→ 46,803 total - Exercise/Conversion
Restricted Stock Units
2024-03-27−22,500→ 0 total→ Common Stock (22,500 underlying) - Tax Payment
Common Stock
2024-03-28$5.59/sh−7,046$39,387→ 39,757 total
Footnotes (4)
- [F1]Represents shares of common stock received upon vesting of a restricted stock unit award.
- [F2]Represents shares used to cover tax withholding on a restricted stock unit release.
- [F3]Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
- [F4]Represents a restricted stock unit award granted on October 11, 2022. These restricted stock units vested as to one half (50%) of the shares on October 11, 2023, and vested as to one half (50%) of the shares on March 27, 2024.
Documents
Issuer
Syros Pharmaceuticals, Inc.
CIK 0001556263
Entity typeother
Related Parties
1- filerCIK 0001479603
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 4:57 PM ET
- Size
- 8.6 KB